Le Lézard4h
Gilead's Seladelpar Granted Conditional European Marketing Authorization for the Treatment of Primary Biliary Cholangitis
Gilead Sciences, Inc. today announced that the European Commission (EC) has granted conditional marketing authorization for seladelpar for the treatment of primary biliary cholangitis (PBC) in ...
MarketWatch22h
Gold Continuous Contract
2-Year U.S. Treasury Note Continuous Contract $102.758 0.020 0.02% 5-Year U.S. Treasury Note Continuous Contract $106.438 0.078 0.07% 10-Year U.S. Treasury Note Continuous Contract $109.063 0.109 ...